annual cash & cash equivalents:
$290.83M-$5.47M(-1.85%)Summary
- As of today (September 3, 2025), ASTH annual cash & cash equivalents is $290.83 million, with the most recent change of -$5.47 million (-1.85%) on December 31, 2024.
- During the last 3 years, ASTH annual cash & cash equivalents has risen by +$4.32 million (+1.51%).
- ASTH annual cash & cash equivalents is now -1.85% below its all-time high of $296.31 million, reached on December 31, 2023.
Performance
ASTH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$342.12M+$81.21M(+31.12%)Summary
- As of today (September 3, 2025), ASTH quarterly cash & cash equivalents is $342.12 million, with the most recent change of +$81.21 million (+31.12%) on June 30, 2025.
- Over the past year, ASTH quarterly cash & cash equivalents has increased by +$14.43 million (+4.40%).
- ASTH quarterly cash & cash equivalents is now -6.14% below its all-time high of $364.49 million, reached on June 1, 2021.
Performance
ASTH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ASTH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | +4.4% |
| 3 y3 years | +1.5% | +25.0% |
| 5 y5 years | +32.3% | +26.7% |
ASTH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.9% | +1.5% | -2.4% | +57.4% |
| 5 y | 5-year | -1.9% | +32.3% | -6.1% | +57.4% |
| alltime | all time | -1.9% | >+9999.0% | -6.1% | >+9999.0% |
ASTH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $342.12M(+31.1%) |
| Mar 2025 | - | $260.91M(-10.3%) |
| Dec 2024 | $290.83M(-1.8%) | $290.83M(-17.0%) |
| Sep 2024 | - | $350.35M(+6.9%) |
| Jun 2024 | - | $327.69M(-2.8%) |
| Mar 2024 | - | $337.29M(+13.8%) |
| Dec 2023 | $296.31M(+0.9%) | $296.31M(+7.0%) |
| Sep 2023 | - | $276.96M(-7.1%) |
| Jun 2023 | - | $298.06M(+6.7%) |
| Mar 2023 | - | $279.43M(-4.8%) |
| Dec 2022 | $293.59M(+2.5%) | - |
| Dec 2022 | - | $293.59M(+35.1%) |
| Sep 2022 | - | $217.30M(-20.6%) |
| Jun 2022 | - | $273.71M(-2.5%) |
| Mar 2022 | - | $280.83M(-2.0%) |
| Dec 2021 | $286.51M(+9.7%) | $286.51M(-14.0%) |
| Sep 2021 | - | $333.33M(-8.6%) |
| Jun 2021 | - | $364.49M(+33.6%) |
| Mar 2021 | - | $272.81M(+4.5%) |
| Dec 2020 | $261.17M(+18.8%) | $261.17M(-8.2%) |
| Sep 2020 | - | $284.39M(+5.3%) |
| Jun 2020 | - | $270.10M(+36.4%) |
| Mar 2020 | - | $198.04M(-9.9%) |
| Dec 2019 | $219.80M(+103.5%) | $219.80M(-5.0%) |
| Sep 2019 | - | $231.47M(+303.2%) |
| Jun 2019 | - | $57.41M(-39.0%) |
| Mar 2019 | - | $94.15M(-12.8%) |
| Dec 2018 | $108.02M(-10.7%) | $108.02M(-16.0%) |
| Sep 2018 | - | $128.57M(+15.2%) |
| Jun 2018 | - | $111.60M(-10.2%) |
| Mar 2018 | - | $124.28M(+2.8%) |
| Dec 2017 | $120.92M(+1204.4%) | $120.92M(+300.3%) |
| Sep 2017 | - | $30.20M(-3.2%) |
| Jun 2017 | - | $31.21M(+260.2%) |
| Mar 2017 | - | $8.66M(-6.5%) |
| Mar 2016 | $9.27M(+84.9%) | $9.27M(+99.6%) |
| Dec 2015 | - | $4.64M(+18.3%) |
| Sep 2015 | - | $3.92M(+0.9%) |
| Jun 2015 | - | $3.89M(-22.4%) |
| Mar 2015 | $5.01M(+240.8%) | $5.01M(-28.3%) |
| Dec 2014 | - | $6.99M(+58.5%) |
| Sep 2014 | - | $4.41M(-28.9%) |
| Jun 2014 | - | $6.21M(+322.1%) |
| Jan 2014 | $1.47M(+25.0%) | $1.47M(+45.4%) |
| Oct 2013 | - | $1.01M(-19.2%) |
| Jul 2013 | - | $1.25M(-20.5%) |
| Apr 2013 | - | $1.58M(+33.9%) |
| Jan 2013 | $1.18M | $1.18M(+134.9%) |
| Oct 2012 | - | $501.00K(+93.4%) |
| Jul 2012 | - | $259.10K(+33.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2012 | - | $193.90K(+17.9%) |
| Jan 2012 | $164.40K(-58.6%) | $164.40K(-34.2%) |
| Oct 2011 | - | $249.70K(-27.2%) |
| Jul 2011 | - | $343.20K(+21.7%) |
| Apr 2011 | - | $281.90K(-29.0%) |
| Jan 2011 | $397.10K(-40.3%) | $397.10K(-20.8%) |
| Oct 2010 | - | $501.60K(-6.1%) |
| Jul 2010 | - | $534.30K(+5.9%) |
| Apr 2010 | - | $504.50K(-24.2%) |
| Jan 2010 | $665.70K(+690.6%) | $665.70K(-22.9%) |
| Oct 2009 | - | $863.40K(+851.9%) |
| Jul 2009 | - | $90.70K(+53.2%) |
| Apr 2009 | - | $59.20K(-29.7%) |
| Jan 2009 | $84.20K(>+9900.0%) | $84.20K(-43.1%) |
| Oct 2008 | - | $148.10K(+63.6%) |
| Jul 2008 | - | $90.50K(>+9900.0%) |
| Apr 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(-100.0%) |
| Mar 2005 | - | $300.00(+200.0%) |
| Dec 2004 | $100.00(-75.0%) | $100.00(0.0%) |
| Sep 2004 | - | $100.00(-50.0%) |
| Jun 2004 | - | $200.00(-33.3%) |
| Mar 2004 | - | $300.00(-25.0%) |
| Dec 2003 | $400.00(+33.3%) | $400.00(+33.3%) |
| Sep 2003 | - | $300.00(-66.7%) |
| Jun 2003 | - | $900.00(+350.0%) |
| Mar 2003 | - | $200.00(-50.0%) |
| Sep 2002 | - | $400.00(0.0%) |
| Jun 2002 | - | $400.00(+33.3%) |
| Mar 2002 | - | $300.00(0.0%) |
| Dec 2001 | $300.00(+50.0%) | $300.00(-25.0%) |
| Sep 2001 | - | $400.00(+33.3%) |
| Jun 2001 | - | $300.00(-50.0%) |
| Mar 2001 | - | $600.00(+20.0%) |
| Sep 2000 | - | $500.00(-44.4%) |
| Jun 2000 | - | $900.00(+125.0%) |
| Mar 2000 | - | $400.00(+100.0%) |
| Dec 1999 | $200.00(-95.2%) | $200.00(-94.7%) |
| Sep 1999 | - | $3800.00(+1166.7%) |
| Jun 1999 | - | $300.00 |
| Dec 1998 | $4200.00 | - |
FAQ
- What is Astrana Health, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Astrana Health, Inc.?
- What is Astrana Health, Inc. annual cash & cash equivalents year-on-year change?
- What is Astrana Health, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Astrana Health, Inc.?
- What is Astrana Health, Inc. quarterly cash & cash equivalents year-on-year change?
What is Astrana Health, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ASTH is $290.83M
What is the all time high annual cash & cash equivalents for Astrana Health, Inc.?
Astrana Health, Inc. all-time high annual cash & cash equivalents is $296.31M
What is Astrana Health, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ASTH annual cash & cash equivalents has changed by -$5.47M (-1.85%)
What is Astrana Health, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ASTH is $342.12M
What is the all time high quarterly cash & cash equivalents for Astrana Health, Inc.?
Astrana Health, Inc. all-time high quarterly cash & cash equivalents is $364.49M
What is Astrana Health, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ASTH quarterly cash & cash equivalents has changed by +$14.43M (+4.40%)